Arterial hypertension and cardiovascular disease - Absolute aldosterone excess is the tip of the iceberg Andreas Tomaschitz;Absoluter Aldosteronexzess, Bluthochdruck und koronare Herzerkrankung

LaboratoriumsMedizin

Volumn 35, Issue 3, 2011, Pages 147-151

  Tomaschitz, Andreas ^a   Pilz, Stefan ^a   März, Winfried ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b SYNLAB ACADEMY   (Germany)

Author keywords

aldosterone; arterial hypertension; cardiovascular disease

Indexed keywords

ALDOSTERONE; MINERALOCORTICOID RECEPTOR; RENIN;

ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GERMANY; HEART DEATH; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MEDICAL SOCIETY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PREVENTIVE MEDICINE; PRIMARY HYPERALDOSTERONISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SALT LOADING; SODIUM RESTRICTION; STROKE;

EID: 80053545565     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2011.020     Document Type: Article

References (21)

1. Whitworth JA. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization WHO)/International Society of Hypertension ISH statement on management of hypertension. J Hypertens 2003;21:1983-92. (Pubitemid 38296854)
2. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. J Am Med Assoc 2003;289:2363-9. (Pubitemid 37430168)
3. Prugger C, Heuschmann PU, Keil U. Epidemiologie der Hypertonie in Deutschland und weltweit. Herz 2006;31:287-93. (Pubitemid 44046491)
4. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93: 3266-81.
5. Schirpenbach C, Segmiller F, Diederich S, Hahner S, Lorenz R, Rump LC, et al. Diagnostik und Therapie des primären Hyperaldosteronismus. Dtsch Arztbl Int 2009;106:305-11.
6. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45: 1243-8. (Pubitemid 40523144)
7. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 2006;48:232-8. (Pubitemid 44309817)
8. Tomaschitz A, Pilz S. Aldosterone to renin ratio- a reliable screening tool for primary aldosteronism ? Horm Metab Res 2010;42:382-91.
9. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002;40:897-902. (Pubitemid 35434913)
10. Pilz S, Tomaschitz A, Stepan V, Obermayer-Pietsch B, Fahrleitner-Pammer A, Schweighofer N, et al. Graz Endocrine Causes of Hypertension GECOH study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism. BMC Endocr Disord 2009;9:11.
11. Tomaschitz A, Pilz S, Ritz E, Obermayer-Pietsch B, Pieber TR. Aldosterone and arterial hypertension. Nat Rev Endocrinol 2010;6:83-93.
12. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004;351: 33-41.
13. Tomaschitz A, März W, Pilz S, Ritz E, Scharnagl H, Renner W, et al. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range. J Am Coll Cardiol 2010;55:2171-80.
14. Vasan RS, Evans JC, Benjamin EJ, Levy D, Larson MG, Sundstrom J, et al. Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 2004;43:957-62. (Pubitemid 38579898)
15. Hollenberg NK. Aldosterone in the development and progression of renal injury. Kidney Int 2004;66:1-9. (Pubitemid 38870076)
16. Tomaschitz A, Pilz S, Ritz E, Meinitzer A, Boehm BO, März W. Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health LURIC study. Eur Heart J 2010;31:1237-47.
17. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, et al. Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health LURIC Study. Am J Kidney Dis 2011;57:403-14.
18. Nowaczynski W, Oliver WJ, Neel JV. Serum aldosterone and protein-binding variables in Yanomama Indians: a no-salt culture as compared to partially acculturated Guaymi Indians. Clin Physiol Biochem 1985;3:289-306. (Pubitemid 16227202)
19. Pratt JH. Central role for ENaC in development of hypertension. J Am Soc Nephrol 2005;16:3154-9. (Pubitemid 46179321)
20. du Cailar G, Fesler P, Ribstein J, Mimran A. Dietary sodium, aldosterone, and left ventricular mass changes during longterm inhibition of the renin-angiotensin system. Hypertension 2010;56:865-70.
21. Lim PO, Struthers AD, MacDonald TM. The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism ? J Hypertens 2002;20:11-5. (Pubitemid 34913396)